CRISPR Therapeutics AG (CRSP) Rose 10.81% or 3.79 To Price $38.85 On Wednesday


CRISPR Therapeutics AG (CRSP) rose 10.81% or 3.79 to $38.85. It is about 1.00 million shares traded, which is 101.3% compare to the average total volume 989487. The market cap of CRSP is $1.84 billion. The year to date change is 50.1%. The 52 week price range is from $16.51 to $73.9. Price of CRSP have changed 6.99% during last week. It have changed -4.10% over last month, -27.61% over last 3 months, -32.21% over last 6 months and 85.40% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CRSP is 42.85. It is 10.30% above current price. The 200-day Moving Averages for CRSP is 49.98. It is 28.65% above current price. The 52-week High is 73.9. It is 90.22% from the current price. The 52-week Low is 16.51. It is -57.50% from current price.

There are some statistics of CRSP. It is has market cap $1.84 billion. The share outstanding is 47.33 million. The average volume is 989487. The revenue is 2.39M. The percent of top 15 Institution holding is 22.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CRSP is -39.04%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CRSP is -27.44%.


Tags:

Share this post